课题基金 / 基金详情

项目摘要

项目成果

THOMAS A GAZIANO的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Cost-effective prevention of cardiovascular disease (CVD) is necessary to avert significant suffering and death in developing countries. The purpose of this International Research Scientist Development Award is to prepare the applicant, Thomas A Gaziano, for a career as an independent investigator in cost-effective CVD prevention in developing countries. Current international guidelines assess risk of CVD on the basis of multiple risk factors including cholesterol and diabetes status. However, the cost of blood testing and a lack of trained staff to obtain samples make these guidelines unsustainable in developing countries. Further, it is unclear how much added information blood sampling provides to other easily obtainable risk factors. Dr. Gaziano proposes a three-year training and research proposal to continue the development of a simple bloodless screening tool for predicting those at highest risk for CVD and then to assess the cost effectiveness of such a strategy in two very different developing countries. The research plan consists of two specific aims. 1. To assess the predictive value of a set of easily obtainable risk factors for CVD --age, tobacco, systolic blood pressure, and an obesity measure (BMI)~ and compare it to the more commonly used model that uses age, tobacco status, blood pressure, lipids and diabetes status. The analysis will be conducted with the Women's Health Study and Physician's Health databases using Cox-proportional hazard modeling. 2. To conduct a cost-effective analysis of screening for CVD using the following strategies: screening without blood sampling, screening with blood sampling, and a third strategy of a two step process of first assessing risk with no blood testing to identify a subset of the population who might benefit from higher cost screening with blood testing. This analysis will be based in part on cost and risk factor prevalence data in the Sentinel Surveillance for CVD in India Study and the Demographic and Health Survey in South Africa. PUBLIC HEALTH RELEVANCE: Eighty percent of cardiovascular deaths occur in developing countries. Assessing those at high risk is an important strategy for prevention. Developing countries have limited resources for strategies that require laboratory testing. We conducted a study to determine if a non laboratory-based risk prediction tool could perform as well as one requiring laboratory information.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.cpcardiol.2009.10.002
发表时间: 2010-02
期刊: CURRENT PROBLEMS IN CARDIOLOGY
影响因子: 4.2
作者: [Gaziano, Thomas A., Bitton, Asaf, Anand, Shuchi, Abrahams-Gessel, Shafika, Murphy, Adrianna]
通讯作者: Murphy, Adrianna
DOI: 10.1016/j.pcad.2010.04.001
发表时间: 2010-07
期刊: PROGRESS IN CARDIOVASCULAR DISEASES
影响因子: 9.1
作者: [Bitton, Asaf, Gaziano, Thomas]
通讯作者: Gaziano, Thomas
Pre-hospital ECG for acute coronary syndrome in urban India: a cost-effectiveness analysis.
印度城市急性冠状动脉综合征的院前心电图:成本效益分析。
DOI: 10.1186/1471-2261-10-13
发表时间: 2010
期刊: BMC cardiovascular disorders
影响因子: 2.1
作者: [Schulman-Marcus,Joshua, Prabhakaran,Dorairaj, Gaziano,ThomasA]
通讯作者: Gaziano,ThomasA
Implementation of a Combination Intervention for Sustainable Blood Pressure Control in Rural KwaZulu-Natal, South Africa (IMPACT-BP)
Implementation of a Combination Intervention for Sustainable Blood Pressure Control in Rural KwaZulu-Natal, South Africa (IMPACT-BP)
PRIMECare Trial: Preventing Ischemic Heart Disease with mHealth, electronic decision support, and Community Health Workers.
  • 批准号:
    10627833
  • 项目类别:
  • 资助金额:
    $62.37万
  • 财政年份:
    2020
  • 负责人:
    THOMAS A GAZIANO
  • 依托单位:
Implementation of a Combination Intervention for Sustainable Blood Pressure Control in Rural KwaZulu-Natal, South Africa (IMPACT-BP)
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: